ArticleJournal of human hypertension2014

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.

L P Hasvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.